Functional impairment in video terminal operators is related to low-grade inflammation

  • Silvia Riondino
  • Francesca La Farina
  • Francesca Martini
  • Fiorella Guadagni
  • Patrizia Ferroni
Original Article

Abstract

Purpose

Progressive functional impairments develop with chronic repetitive tasks possibly involving inflammatory mediators. Aim of this study was to analyze systemic inflammatory changes in relation to the possible occurrence of pain and/or disability in video terminal operators (VTOs) undergoing upper-extremity repetitive stress due to chronic overuse.

Methods

Pain assessments, classification, and grade of impairment relied on self-report questionnaires administered to 21 VTOs and to 21 matched controls. The inflammatory status of the enrolled subjects was analyzed by determination of serum high sensitive C-reactive protein (hs-CRP) as well as systemic levels or monocyte expression of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α).

Results

Serum levels of both cytokines were increased in VTOs compared to controls (P = 0.005 for TNF-α and P = 0.004 for IL-6). TNF-α levels correlated to IL-6 (P = 0.019), which, in turn, was associated to increased hs-CRP (P = 0.012). DASH score allowed to categorize VTOs according to disability. VTOs with mild (DASH = 22) or moderate (DASH = 46) disability (n = 10) had higher serum hs-CRP (P = 0.001) and IL-6 (P = 0.035) levels than VTOs without disabilities (DASH < 17) (n = 11). Monocyte stimulatory TNF-α expression was increased in individuals with mild/moderate disability. Monocyte expression of TNF-α was independently associated to that of IL-6, which, in turn, was associated to increased systemic hs-CRP levels together with mild/moderate functional impairment and weekly commitment to the display screen.

Conclusions

The results here reported indicate the occurrence of a low-grade inflammatory condition in VTOs with mild/moderate disability, which might allow the early recognition of arising musculoskeletal disorders induced by repetitive stress.

Keywords

Video terminal operators IL-6 TNF-α Low-grade inflammation Pain scale 

References

  1. Alfredson H, Forsgren S, Thorsen K, Fahlstrom M, Johansson H, Lorentzon R (2001) Glutamate NMDAR1 receptors localised to nerves in human Achilles tendons. Implications for treatment? Knee Surg Sports Traumatol Arthrosc 9:123–126CrossRefGoogle Scholar
  2. Al-Shatti T, Barr AE, Safadi F, Amin M, Barbe MF (2005) Increase in pro- and anti-inflammatory cytokines in median nerves in a rat model of repetitive motion injury. J Neuroimmunol 167:13–22CrossRefGoogle Scholar
  3. Backman C, Boquist L, Friden J, Lorentzon R, Toolanen G (1990) Chronic achilles paratenonitis with tendinosis: an experimental model in the rabbit. J Orthop Res 8:541–547CrossRefGoogle Scholar
  4. Barbe MF, Barr AE, Gorzelany I, Amin M, Gaughan JP, Safadi FF (2003) Chronic repetitive reaching and grasping results in decreased motor performance and widespread tissue responses in a rat model of MSD. J Orthop Res 21:167–176CrossRefGoogle Scholar
  5. Beaton DE, Katz NK, Fossel AH, Wright JG, Tarasuk V, Bombardier C (2001) Measuring the whole of the parts? Validity, reliability, and responsiveness of Disabilities of the Arm Shoulder and Hand outcome measure in different regions of the upper limb. J Hand Ther 14:128–146Google Scholar
  6. Biffi WL, Moore EE, Moore FA, Peterson VM (1996) Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann. Surg 224:647–664Google Scholar
  7. Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E et al (2004) Development and validation of the Neuropathic Pain Symptom Inventory. Pain 108:248–257CrossRefGoogle Scholar
  8. Bureau of Labor Statistics News, United States Department of Labor (2008) Nonfatal occupational injuries and illnesses requiring days away from work for State government and local government workers. Available at http://www.bls.gov/iif/home.htm. Accessed 11 June 2010
  9. Campligio GL, Di Giuseppe P, Migliorini L, Cazzaniga M, Lamperti E, Romorini A (1999) Histopathology of the flexor tendon sheaths and its relevance in idiopathic carpal tunnelsyndrome. Eur J Plast Surg 22:230–233CrossRefGoogle Scholar
  10. Carp SJ, Barbe MF, Winter KA, Amin M, Barr AE (2007) Inflammatory biomarkers increase with severity of upper-extremity overuse disorders. Clin Sci 112:305–314CrossRefGoogle Scholar
  11. Carpenter JE, Flanagan CL, Thomopoulos S, Yian EH, Soslowsky LJ (1998) The effects of overuse combined with intrinsic or extrinsic alterations in an animal model of rotator cuff tendinosis. Am J Sports Med 26:801–807Google Scholar
  12. Chan MH, Carey AL, Watt MJ, Febbraio MA (2004) Cytokine gene expression in human skeletal muscle during concentric contraction: evidence that IL-8, like IL-6, is influenced by glycogen availability. Am J Physiol Regulatory Integrative Comp Physiol 287:R322–R327CrossRefGoogle Scholar
  13. Fuss IJ, Kanof ME, Smith PD, Zola H (2009) Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr Protoc Immunol 85:7.1.1–7.1.8Google Scholar
  14. Gerr F, Marcus M, Ensor C, Kleinbaum D, Cohen S, Edwards A et al (2002) A prospective study of computer users: I. Study design and incidence of musculoskeletal symptoms and disorders. Am J Ind Med 41:221–235CrossRefGoogle Scholar
  15. Haider DG, Leuchten N, Schaller G, Gouya G, Kolodjaschna J, Schmetterer L et al (2006) C-reactive protein is expressed and secreted by peripheral blood mononuclear cells. Clin Exp Immunol 146:533–539CrossRefGoogle Scholar
  16. Heinrich PC, Castell JV, Andus T (1990) Interleukin-6 and the acute phase response. Biochem J 265:621–636Google Scholar
  17. Hudak PL, Amadio PC, Bombardier C (1996) Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am J Ind Med 29:602–608CrossRefGoogle Scholar
  18. Hunsaker FG, Cioffi DA, Amadio PC, Wright JC, Caughlin B (2002) The American Academy of Orthopaedic Surgeons’ Outcomes Instruments—normative values from the general population. J Bone Joint Surg 84:208–215Google Scholar
  19. Huskisson E (1982) Measurement of pain. J Rheumatol 9:768–769Google Scholar
  20. IASP Task Force on Taxonomy (1994) IASP pain terminology. In: Merskey H, Bogduk N (eds) Classification of chronic pain, 2nd edn. IASP Press, Seattle. Available at: http://www.iasp-pain.org/AM/Template.cfm?Section=Pain_Defi…isplay.cfm&ContentID=1728#Neuropathic. Accessed 11 June 2010
  21. Jones SA (2005) Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 175:3463–3468Google Scholar
  22. Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM (2001) The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 15:43–58CrossRefGoogle Scholar
  23. Messner K, Wei Y, Andersson B, Gillquist J, Rasanen T (1999) Rat model of Achilles tendon disorder. A pilot study. Cells Tissues Organs 165:30–39CrossRefGoogle Scholar
  24. Mihara M, Moriya Y, Kishimoto T, Ohsugi Y (1995) Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol 34:321–325CrossRefGoogle Scholar
  25. Pedersen BK, Steensberg A, Schjerling P (2001) Muscle-derived interleukin-6: possible biological effects. J Physiol 526:329–337CrossRefGoogle Scholar
  26. Portenoy R (2006) Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin 22:1555–1565CrossRefGoogle Scholar
  27. Roquelaure Y, Ha C, Rouillon C, Fouquet N, Leclerc A, Descatha A et al (2009) Risk factors for upper-extremity musculoskeletal disorders in the working population. Arthritis Rheum 61:1425–1434CrossRefGoogle Scholar
  28. Soslowsky LJ, Thomopoulos S, Esmail A, Flanagan CL, Iannotti JP, Williamson JD 3rd et al (2002) Rotator cuff tendinosis in an animal model: role of extrinsic and overuse factors. Ann Biomed Eng 30:1057–1063CrossRefGoogle Scholar
  29. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW (1994) Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83:113–118Google Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Silvia Riondino
    • 1
  • Francesca La Farina
    • 1
  • Francesca Martini
    • 1
  • Fiorella Guadagni
    • 2
  • Patrizia Ferroni
    • 1
  1. 1.Laboratory of Thrombosis and Haemostasis, Department of Laboratory Medicine and Advanced BiotechnologiesIRCCS San RaffaeleRomeItaly
  2. 2.InterInstitutional Multidisciplinary Biobank (BioBIM), Department of Laboratory Medicine and Advanced BiotechnologiesIRCCS San RaffaeleRomeItaly

Personalised recommendations